ReGenTree, LLC (the Company), a joint venture company between GtreeBNT and RegeneRx Biopharmaceuticals, announced that it initiated a randomized, double masked, placebo-controlled Phase 3 clinical trial (ARISE-3) for dry eye syndrome on May 10. The objective of the...
CRF Bracket, a leading patient-centric clinical technology company, has increased its strategic investment in the Asia-Pacific Region with the opening of a new office in Tokyo, Japan. A ribbon cutting ceremony was held on 8 May in the Roppongi district of the city,...
Polarean Imaging PLC on Monday said that it is progressing on its phase III clinical trials and plans to add an extra site in its lung resection pathway trial to improve the rate of enrollment. The company is carrying out two trials at Duke University and at the...
Hemispherx Biopharma Inc., (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases, announced progress toward the opening of Roswell Park Comprehensive...
ClinOne is pleased to announce that Dr. Elizabeth Esterl joins ClinOne as our VP of Operations and Research. Dr. Esterl brings with her a depth and breadth of knowledge in clinical trials spanning her 20+ year career in research, including over 13 years at Children’s...
Email
Text